ドライアイ製品の世界市場

ドライアイ製品の世界市場は2030年までに87億米ドルに達する見込み

2024年に71億米ドルと推定されるドライアイ製品の世界市場は、2024年から2030年にかけてCAGR 3.6%で成長し、2030年には87億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである人工涙液は、CAGR 4.6%を記録し、分析期間終了時には36億米ドルに達すると予想されます。抗炎症薬セグメントの成長率は、分析期間中CAGR 2.1％と推定されます。

米国市場は19億米ドル、中国はCAGR6.9%で成長すると予測

米国のドライアイ製品市場は2024年に19億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の「ドライアイ製品」市場- 主要動向と促進要因のまとめ

なぜ世界はドライアイ対策にこれまで以上に力を注いでいるのか？

世界の「ドライアイ製品」市場は、先進経済諸国と新興経済諸国の両方におけるドライアイ（DED）発症率の急上昇に牽引され、力強い拡大局面を迎えています。デジタル機器の使用によるスクリーン使用時間の増加、長時間の屋内活動、まばたき回数の減少などのライフスタイルの変化が、この疾患の有病率上昇に大きく寄与しています。特に日本、イタリア、ドイツなどの国々では高齢化が進んでおり、加齢に伴う涙腺の機能障害も大きな影響を及ぼしています。汚染、空調、季節的な乾燥などの環境要因は、さらに症状を悪化させる。その結果、消費者は様々な市販（OTC）や処方箋入りの目薬、ジェル、軟膏、器具による救済を積極的に求めています。ヘルスケアプロバイダーやビジョンケアブランドのキャンペーンに支えられた目の健康と快適さに対する意識の高まりは、効果的で利用しやすい解決策への関心を高め、ドライアイ治療を眼科治療薬セクターの主要な焦点にしています。

製剤の進歩はドライアイ患者の救済をどのように再定義しているか？

製剤の革新は、市場競争情勢を再構築しています。製薬会社やバイオテクノロジー企業は、水不足型や蒸発型など、さまざまなタイプのドライアイに対応できるよう、防腐剤フリー、脂質強化、持続時間の長い製品の開発にますます力を入れています。シクロスポリン、ライフィテグラスト、ヒアルロン酸のような新規成分の配合は、より深い保湿と抗炎症効果をもたらし、症状の緩和と治療効果の両方を提供するのに役立っています。眼表面の炎症に対処しながら潤滑を提供するデュアルアクションソリューションが注目を集めています。また、無菌性を維持しながら刺激を最小限に抑える防腐剤フリーのマルチ用量ディスペンサーの需要も急増しています。臨床革新は目薬だけにとどまらないです。補助的治療として、熱脈動装置、穿刺プラグ、ウェアラブル涙刺激技術が台頭しており、薬剤を使わない、あるいは非侵襲的アプローチを好む消費者に対応しています。このような先進的で個別化された製品の数々は、治療の可能性をかつてないほど広げています。

アイケア製品の販売とアクセシビリティを形成している消費者動向と小売動向とは？

ドライアイ製品の商品化は消費者中心になりつつあり、eコマース・チャンネル、薬局チェーン、視力専門クリニックが小売の重要な戦場となっています。デジタル薬局や遠隔医療プラットフォームは、一般用医薬品と処方箋医薬品の両方へのアクセスを合理化しており、その多くは現在、眼科専門医とのオンライン相談を提供しています。このような流通戦略の転換は、農村部や移動に制限のある人々にサービスを提供する上で特に効果的です。さらに、製品のプレミアム化の波が市場を席巻しており、より早い効き目、より長い装用時間、オーガニック／天然成分などの高級処方が、健康志向の消費者にアピールしています。スマートディスペンサーや1回使い切りバイアル瓶のようなパッケージング革新は、ユーザーの利便性と衛生性を高めています。マーケティング戦略はますますデータ主導型になっており、ブランドは目の健康意識向上キャンペーン、インフルエンサーとの提携、AIを活用した広告を駆使して、特に中高年女性、オフィスワーカー、高齢者など特定の層を啓蒙し、取り込んでいます。このような消費者ニーズと小売イノベーションの相乗効果により、ドライアイケアプロバイダーは新たな成長の道を切り開こうとしています。

ドライアイ製品世界市場の成長を促進する要因とは？

ドライアイ製品市場の成長は、いくつかの要因によって牽引されています。ドライアイ疾患の世界の有病率の上昇は、スクリーンへの露出の増加、人口動態の高齢化、環境刺激物によって拍車がかかり、対処可能な市場を直接的に拡大しています。防腐剤フリーのオプション、抗炎症化合物、脂質ベースの目薬など、製品処方の進歩は、より効果的で的を絞った治療を提供し、幅広い採用を促しています。消費者行動の面では、眼精疲労や予防的なアイケアに対する意識の高まりが、日常用と長期治療用の両方の製品に対する需要を促進しています。さらに、デジタルヘルスプラットフォームの拡大や、サブスクリプションモデル、バーチャル診察、戸別配達などの小売イノベーションが、製品へのアクセス性と消費者の関与を高めています。新しい処方箋製剤や医療機器に対する規制当局の承認も、技術革新と多様化を後押ししています。臨床的進歩、消費者教育、規制当局の支援、技術的利便性といったこれらの複合的な力が、ドライアイ製品市場の世界の急速かつ持続的な成長を後押ししています。

セグメント

製品タイプ（OTCドライアイ製品、処方薬ドライアイ製品）、剤形（点眼剤、ゲル剤、カプセル・錠剤）、流通チャネル（小売薬局、病院薬局、オンライン）

調査対象企業の例（合計 34注目）

• AbbVie Inc.
• AFT Pharmaceuticals
• Akorn, Inc.
• Alcon Inc.
• Bausch Health Companies Inc.
• Horus Pharma
• Johnson & Johnson Vision Care, Inc.
• Mitotech S.A.
• Novaliq GmbH
• Novartis AG
• OASIS Medical, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Rohto Pharmaceutical Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Sentiss Pharma Pvt. Ltd.
• Sight Sciences, Inc.
• Similasan AG
• Sun Pharmaceutical Industries Ltd.
• TearScience, Inc.
• VISUfarma B.V.

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Dry Eye Products Market to Reach US$8.7 Billion by 2030

The global market for Dry Eye Products estimated at US$7.1 Billion in the year 2024, is expected to reach US$8.7 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Artificial Tears, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Anti-Inflammatory Drugs segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 6.9% CAGR

The Dry Eye Products market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global "Dry Eye Products" Market - Key Trends & Drivers Summarized

Why Is the World Blinking More Toward Dry Eye Solutions Than Ever Before?

The global dry eye products market has entered a phase of robust expansion, driven by a sharp rise in the incidence of dry eye disease (DED) across both developed and emerging economies. Lifestyle changes, including increased screen time from digital device usage, prolonged indoor activity, and reduced blink rates, have significantly contributed to the rising prevalence of this condition. Aging populations-particularly in countries like Japan, Italy, and Germany-are also highly susceptible due to age-related tear gland dysfunction. Environmental factors such as pollution, air conditioning, and seasonal dryness further exacerbate symptoms. As a result, consumers are actively seeking relief through a wide variety of over-the-counter (OTC) and prescription eye drops, gels, ointments, and devices. The growing awareness of eye health and comfort, supported by campaigns from healthcare providers and vision care brands, is drawing greater attention to effective and accessible solutions, making dry eye treatment a major focus within the ocular therapeutics sector.

How Are Formulation Advances Redefining Relief for Dry Eye Sufferers?

Innovation in formulations is reshaping the competitive landscape of the dry eye products market. Pharmaceutical and biotech firms are increasingly focusing on creating preservative-free, lipid-enhanced, and longer-lasting products that can address different types of DED, such as aqueous-deficient and evaporative forms. The inclusion of novel ingredients like cyclosporine, lifitegrast, and hyaluronic acid is helping to deliver deeper hydration and anti-inflammatory effects, offering both symptomatic relief and therapeutic benefit. Dual-action solutions that provide lubrication while addressing inflammation at the ocular surface are gaining prominence. There's also a surge in demand for preservative-free multi-dose dispensers, which minimize irritation while maintaining sterility-an essential feature for chronic sufferers. Clinical innovation isn’t limited to eye drops; thermal pulsation devices, punctal plugs, and wearable tear-stimulating tech are emerging as adjunctive treatments, catering to consumers who prefer drug-free or non-invasive approaches. This wide array of advanced, personalized products is expanding treatment possibilities like never before.

What Consumer and Retail Trends Are Reshaping the Sales and Accessibility of Eye Care Products?

The commercialization of dry eye products is becoming more consumer-centric, with e-commerce channels, pharmacy chains, and specialty vision clinics becoming key retail battlegrounds. Digital pharmacies and telemedicine platforms are streamlining access to both OTC and prescription products, with many now offering online consultations with eye care specialists. This shift in distribution strategy is particularly effective in serving rural or mobility-restricted populations. Additionally, a wave of product premiumization is sweeping the market, with high-end formulations offering faster relief, longer wear times, or organic/natural ingredients, appealing to health-conscious consumers. Packaging innovations-like smart dispensers and single-use vials-are enhancing user convenience and hygiene. Marketing strategies are increasingly data-driven, with brands using eye health awareness campaigns, influencer partnerships, and AI-backed advertising to educate and engage specific demographics, especially middle-aged women, office workers, and the elderly. This synergy between consumer needs and retail innovation is unlocking new growth avenues for dry eye care providers.

What Forces Are Driving the Growth of the Global Dry Eye Products Market?

The growth in the dry eye products market is driven by several factors. The rising global prevalence of dry eye disease-spurred by increased screen exposure, aging demographics, and environmental irritants-is directly expanding the addressable market. Advances in product formulation, including preservative-free options, anti-inflammatory compounds, and lipid-based eye drops, are offering more effective and targeted treatments, encouraging broader adoption. On the consumer behavior front, heightened awareness about eye strain and preventive eye care has spurred demand for both daily-use and long-term therapeutic products. Moreover, the expansion of digital health platforms and retail innovations-such as subscription models, virtual consultations, and doorstep delivery-are enhancing product accessibility and consumer engagement. Regulatory approvals for newer prescription formulations and medical devices are also supporting innovation and diversification. These combined forces-clinical advancement, consumer education, regulatory support, and technological convenience-are propelling the rapid and sustained growth of the dry eye products market worldwide.

SCOPE OF STUDY:

The report analyzes the Dry Eye Products market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements); Type (OTC Dry Eye Products, Prescription Dry Eye Products); Dosage Form (Eye Drops Form, Gel Form, Capsules & Tablets Form); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• AbbVie Inc.
• AFT Pharmaceuticals
• Akorn, Inc.
• Alcon Inc.
• Bausch Health Companies Inc.
• Horus Pharma
• Johnson & Johnson Vision Care, Inc.
• Mitotech S.A.
• Novaliq GmbH
• Novartis AG
• OASIS Medical, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Rohto Pharmaceutical Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Sentiss Pharma Pvt. Ltd.
• Sight Sciences, Inc.
• Similasan AG
• Sun Pharmaceutical Industries Ltd.
• TearScience, Inc.
• VISUfarma B.V.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Dry Eye Products - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Screen-Induced Eye Strain Drives Demand for Dry Eye Remedies
  • Aging Population and Hormonal Changes Expand the Dry Eye Treatment Market
  • Increasing Diagnosis Rates and Patient Awareness Accelerates Market Growth
  • Shift Toward Preservative-Free Formulations Sustains Demand for Premium Products
  • Surge in Refractive Surgeries Throws Spotlight on Post-Operative Eye Lubricants
  • Increasing Contact Lens Usage Spurs Demand for Rewetting Drops and Gels
  • Innovation in Long-Lasting Artificial Tear Technologies Drives Adoption
  • Integration of Digital Therapeutics and Telehealth Supports Product Accessibility
  • Chronic Eye Conditions and Autoimmune Disorders Expand Prescription Product Demand
  • Inclusion in Vision Insurance Plans Enhances Market Access and Affordability
  • Growth in Pediatric Dry Eye Cases Opens New Product Development Opportunities
  • Launch of Combination Therapy Products Spurs Growth of Multimodal Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Dry Eye Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Dry Eye Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Dry Eye Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Dry Eye Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Artificial Tears by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Punctal Plugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Punctal Plugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Punctal Plugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Secretagogues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Secretagogues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Secretagogues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Oral Omega Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Oral Omega Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Oral Omega Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Capsules & Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Capsules & Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Capsules & Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Eye Drops Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Eye Drops Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Eye Drops Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Gel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Gel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Gel Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for OTC Dry Eye Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for OTC Dry Eye Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for OTC Dry Eye Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Prescription Dry Eye Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Prescription Dry Eye Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Prescription Dry Eye Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• JAPAN
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• CHINA
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: China 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• EUROPE
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Dry Eye Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Dry Eye Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Dry Eye Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• FRANCE
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: France 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: France 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• GERMANY
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Germany 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Italy 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 143: UK Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: UK 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Spain 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Russia 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Dry Eye Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 16-Year Perspective for Dry Eye Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Australia 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• INDIA
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 218: India Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: India 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: India 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: South Korea 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Dry Eye Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Latin America 16-Year Perspective for Dry Eye Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Argentina 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Brazil 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Mexico 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Dry Eye Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Middle East 16-Year Perspective for Dry Eye Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Iran 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Israel 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: UAE 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030
• AFRICA
  • Dry Eye Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Dry Eye Products by Product - Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Africa 16-Year Perspective for Dry Eye Products by Product - Percentage Breakdown of Value Sales for Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues and Oral Omega Supplements for the Years 2014, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Dry Eye Products by Dosage Form - Capsules & Tablets Form, Eye Drops Form and Gel Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Dry Eye Products by Dosage Form - Percentage Breakdown of Value Sales for Capsules & Tablets Form, Eye Drops Form and Gel Form for the Years 2014, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Dry Eye Products by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Dry Eye Products by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Dry Eye Products by Type - OTC Dry Eye Products and Prescription Dry Eye Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for Dry Eye Products by Type - Percentage Breakdown of Value Sales for OTC Dry Eye Products and Prescription Dry Eye Products for the Years 2014, 2025 & 2030

IV. COMPETITION